Tooth regeneration therapies refers to medical procedures
that focus on repairing damaged or diseased teeth. These therapies use advance
technologies like stem cells, tissue engineering or scaffold technique to
regenerate degraded dental tissues. Stem cells have the potential to
differentiate into specialized tooth tissues and regenerate teeth in areas that
have suffered from decay, injury or malformations. Growth in dental stem cell
research is expected to drive development of effective tooth regeneration
therapies. These therapies will help in re-growing lost teeth structure without
the need of artificial crowns, veneers or dental implants. Moreover, with
regenerative therapies, amount of tooth decay can be reduced, ultimately limiting
the need for dental fillings and extractions.
The global tooth regeneration market is estimated to be
valued at US$ 4530.6 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over
the forecast period 2023-2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
Increase in regenerative therapies is one of the major trend being witnessed in
the tooth regeneration market. Rising number of clinical trials evaluating
efficacy and safety of regenerative dental therapy approaches such as stem cell
therapy, biomaterial scaffold technology and tissue engineering are expected to
drive market growth during forecast period. Currently more than 100 clinical
trials are underway which are analyzing potential of these novel approaches to
restore degraded tooth structures. Few companies have started commercializing
their tooth regeneration products as well. Successful launch of these products
in future will mark a paradigm shift from restorative to regenerative
dentistry.
Segment Analysis
The global
tooth
regeneration market is dominated by the dental stem cells sub-segment which
currently holds around 35% of the market share. Dental stem cells are
considered more effective compared to other treatments as they can
differentiate themselves into the multiple cell types required for natural
tooth formation such as odontoblasts, cementoblasts and osteoblasts. This makes
stem cell therapy a promising approach for tooth regeneration.
Key Takeaways
The global tooth regeneration market is estimated to
be valued at US$ 4530.6 Mn in 2023 and is expected to exhibit a CAGR of 5.8%
over the forecast period 2023-2030.
North America currently accounts for the largest share of the tooth
regeneration market owing to factors such as presence of advanced healthcare
infrastructure, rising incidence of dental disorders and growing awareness
about oral healthcare. However, Asia Pacific is expected to witness the fastest
growth over the forecast period due strong economic growth, rising healthcare
expenditure and gradual acceptance of advanced dental treatments.
Key players: Key players operating in the tooth regeneration market are
Institute Straumann AG, DENTSPLY Sirona, Datum Dental, Camlog Biotechnologies
AG, BioHorizons, Unilever, 3M, Zimmer Biomet, Ocata Therapeutics, Integra
LifeSciences, CryoLife, BioMimetic Therapeutic, Cook Medical, Stem Cells Inc.
DENTSPLY Sirona dominates the market with its wide product portfolio of dental
stem cells and biomaterials for tooth regeneration. Camlog Biotechnologies AG
is another leading player known for its growth factor enriched gels used in
tooth tissue engineering. Integra LifeSciences conducts extensive R&D for
developing skin and bone substitute biomaterials for dental applications.
Comments
Post a Comment